Medicina intensiva

2018

1. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer

   Carcinogenesis, Vol. 39, Núm. 7, pp. 921-930

2. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study

   Intensive Care Medicine, Vol. 44, Núm. 8, pp. 1212-1220

3. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review

   Clinical Pharmacokinetics, Vol. 57, Núm. 9, pp. 1107-1121

4. Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit

   Journal of Critical Care, Vol. 48, pp. 172-177

5. Clinical profile of the critically ill elderly patient. Prognosis and factors related to mortality

   Acta Colombiana de Cuidado Intensivo, Vol. 18, Núm. 2, pp. 84-91

6. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

   Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344

7. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

   Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

8. Iktusa Farmaziaren ikuspegitik

   Osagaiz: osasun-zientzien aldizkaria, Vol. 2, Núm. 1, pp. 79-82

9. Invasive device-associated infections caused by Pseudomonas aeruginosa in critically ill patients: evolution over 10 years

   Journal of Hospital Infection, Vol. 100, Núm. 3, pp. e204-e208

10. Population pharmacokinetics of daptomycin in critically ill patients

    International Journal of Antimicrobial Agents, Vol. 52, Núm. 2, pp. 158-165

11. Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design: The ASAF trial: ablation of sympathetic atrial fibrillation

    Clinical Research in Cardiology, Vol. 107, Núm. 7, pp. 539-547